Low doses of insulin-like growth factor I improve insulin resistance, lipid metabolism, and oxidative damage in aging rats

Endocrinology

Volumn 149, Issue 5, 2008, Pages 2433-2442

  García Fernández, María ^a   Delgado, Gloria ^a   Puche, Juan Enrique ^a,b   González Barón, Salvador ^a   Cortázar, Inma Castilla ^a,b  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FATTY ACID; SOMATOMEDIN C; TESTOSTERONE; TRIACYLGLYCEROL;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; GLUCOSE METABOLISM; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPID METABOLISM; LOW DRUG DOSE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ADENOSINE TRIPHOSPHATE; AGING; ANIMALS; ANTIOXIDANTS; BRAIN; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; LIPID METABOLISM; LIVER; MALE; MATRIX METALLOPROTEINASES; MITOCHONDRIA, LIVER; MODELS, ANIMAL; MODELS, BIOLOGICAL; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 42449105754     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1190     Document Type: Article

References (54)

1. Tollet-Egnell P, Flores-Morales A, Odeberg J, Lundeberg J, Norstedt G 2000 Differential cloning of growth hormone-regulated hepatic transcripts in the aged rat. Endocrinology 141:910-921
2. Sonntag WE, Lynch CD, Cooney PT, Hutchins PM 1997 Decreases in cerebral microvasculature with age are associated with the decline in growth hormone and insulin-like growth factor 1. Endocrinology 138:3515-3520
3. Sun LY, Al-Regaiey K, Masternak MM, Wang J, Bartke A 2005 Local expression of GH and IGF-1 in the hippocampus of GH-deficient long-lived mice. Neurobiol Aging 26:929-937
4. Ceda GP, Dall'Aglio E, Maggio M, Lauretani F, Bandinelli S, Falzoi C, Grimaldi W, Ceresini G, Corradi F, Ferrucci L, Valenti G, Hoffman AR 2005 Clinical implications of the reduced activity of the GH-IGF-I axis in older men. J Endocrinol Invest 28:96-100
5. Laron Z, Pertzelan A, Mannheimer S 1966 Genetic pituitary dwarfism with high serum concentration of growth hormone-a new inborn error of metabolism? Isr J Med Sci 2:152-155
6. Laron Z 1996 Short stature due to genetic defects affecting growth hormone activity. N Engl J Med 334:463-465
7. Klinger B, Laron Z 1995 Three year IGF-I treatment of children with Laron syndrome. J Pediatr Endocrinol Metab 8:149-158
8. Wu A, Grant DB, Hambley J, Levi AJ 1974 Reduced serum somatomedin activity in patients with chronic liver disease. Clin Sci Mol Med 47:359-366
9. Picardi A, de Oliveira AC, Muguerza B, Tosar A, Quiroga J, Castilla-Cortázar I, Santidrian S, Prieto J 1997 Low doses of insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis. J Hepatol 26:191-202
10. Castilla-Cortázar I, Prieto J, Urdaneta E, Pascual M, Nuñez M, Zudaire E, Prieto J 1997 Impaired intestinal sugar transport in cirrhotic rats: correction by low doses of insulin-like growth factor I. Gastroenterology 113:1180-1187
11. Castilla-Cortázar I, Picardi A, Ainzua J, Urdaneta E, Pascual M, García M, Pascual M, Quiroga J, Prieto J 1999 Effect of insulin-like growth factor I on in vivo intestinal absorption of D-galactose in cirrhotic rats. Am J Physiol 276(1 Pt 1):37-42
12. Castilla-Cortazar I, Pascual M, Urdaneta E, Pardo J, Puche JE, Vivas B, Diaz-Casares A, Garcia M, Diaz-Sanchez M, Varela-Nieto I, Castilla A, Gonzalez-Baron S 2004 Jejunal microvilli atrophy and reduced nutrient transport in rats with advanced liver cirrhosis: improvement by insulin-like growth factor I. BMC Gastroenterol 4:12-20
13. Cemborain A, Castilla-Cortázar I, García M, Quiroga J, Muguerza B, Picardi A, Santidrian S, Prieto J 1998 Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I-treatment. J Hepatol 28:122-131
14. Castilla-Cortázar I, García M, Quiroga J, Diez N, Diez-Caballero F, Calvo A, Diaz M, Prieto J 2000 Insulin-like growth factor I reverts testicular atrophy in rats with advanced liver cirrhosis. Hepatology 31:592-600
15. Castilla-Cortazar I, Diez N, Garcia-Fernandez M, Puche JE, Diez-Caballero F, Quiroga J, Diaz-Sanchez M, Castilla A, Casares AD, Varela-Nieto I, Prieto J, Gonzalez-Baron S 2004 Hematotesticular barrier is altered from early stages of liver cirrhosis: effect of Insulin-like growth factor 1. World J Gastroenterol 10:2529-2534
16. Castilla-Cortázar I, García M, Muguerza B, Perez R, Quiroga J, Santidrián S, Prieto J 1997 Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis. Gastroenterology 113:1682-1691
17. Garcia-Fernandez M, Castilla-Cortazar I, Diaz-Sanchez M, Navarro I, Puche JE, Castilla A, Casares AD, Clavijo E, Gonzalez-Baron S 2005 Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis. BMC Gastroenterol 5:7
18. García-Fernández M, Castilla-Cortázar I, Díaz-Sánchez M, Diez-Caballero F, Castilla A, Díaz Casares A, Varela-Nieto I, González-Barón S 2003 Effect of IGF-I on total serum antioxidant status in cirrhotic rats. J Physiol Biochem 59:145-146
19. Mirpuri E, Garcia-Trevijano ER, Castilla-Cortazar I, Berasain C, Quiroga J, Rodriguez-Ortigosa C, Mato JM, Avila M, Prieto J 2002 Altered liver gene expression in CCl4-cirrhotic rats is partially normalized by insulin-like growth factor-I. Int J Biochem Cell Biol 34:242-252
20. Holzenberger M 2004 The GH/IGF-I axis and longevity. Eur J Endocrinol 151(Suppl 1):S23-S27
21. Shimokawa I, Higami Y, Tsuchiya T, Otani H, Komatsu T, Chiba T, Yamaza H 2003 Life span extension by reduction of the growth hormone-insulin-like growth factor-1 axis: relation to caloric restriction. FASEB J 17:1108-1109
22. Sonntag WE, Carter CS, Ikeno Y, Ekenstedt K, Carlson CS, Loeser RF, Chakrabarty S, Lee S, Bennett C, Ingram R, Moore T, Ramsey M 2005 Adult-onset growth hormone and insulin-like growth factor I deficiency reduces neoplastic disease, modifies age-related pathology, and increases life span. Endocrinology 146:2920-2932
23. Fernandez S, Fernandez AM, Lopez-Lopez C, Torres-Aleman I 2007 Emerging roles of insulin-like growth factor-I in the adult brain. Growth Horm IGF Res 17:89-95
24. Thum T, Hoeber S, Froese S, Klink I, Stichtenoth DO, Galuppo P, Jakob M, Tsikas D, Anker SD, Poole-Wilson PA, Borlak J, Ertl G, Bauersachs J 2007 Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ Res 100:434-443
25. Li Q, Wu S, Li SY, Lopez FL, Du M, Kajstura J, Anversa P, Ren J 2007 Cardiac-specific overexpression of insulin-like growth factor 1 attenuates aging-associated cardiac diastolic contractile dysfunction and protein damage. Am J Physiol Heart Circ Physiol 292:1398-403
26. Trejo JL, Carro E, Lopez-Lopez C, Torres-Aleman I 2004 Role of serum insulin-like growth factor I in mammalian brain aging. Growth Horm IGF Res 14(Suppl A):S39-S43
27. Miller NJ, Rice-Evans C, Davies MJ 1993 A new method for measuring antioxidant activity. Biochem Soc Trans 21:95S
28. Voss P, Siems W 2006 Clinical oxidation parameters of aging. Free Radic Res 40:1339-1349
29. Cardoso SM, Pereira C, Oliveira CR 1999 Mitochondrial function is differentially affected upon oxidative stress. Free Radic Biol Med 26:3-13
30. Esterbauer H, Schaur RJ, Zollner H 1991 Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad Biol Med 11:81-128
31. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER 1990 Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464-478
32. Richter C, Gogvadze V, Laffranchi R, Schlapbach R, Schwelver M, Suter M, Walter P, Yafffee M 1995 Oxidant in mitochondria: from physiology to diseases. Biochim Biophys Acta 1271:67-74
33. Kowaltowski AJ, Vercesi E 1999 Mitochondrial damage induced by conditions of oxidative stress. Free Radic Biol Med 26:463-471
34. Harris ED 1992 Regulation of antioxidant enzymes. FASEB J 6:2675-2683
35. O'Connor JE, Vargas JL, Kimler BF, Hernandez-Yago J, Grisolia S 1988 Use of rhodamine 123 to investigate alterations in mitochondrial activity in isolated mouse liver mitochondria. Biochem Biophys Res Commun 151:568-573
36. National Academy of Sciences 1991 The guiding principles for research involving animals. Bethesda, MD: National Institutes of Health
37. Wallace TM, Levy JC, Matthews DR 2004 Use and abuse of HOMA modeling. Diabetes Care 27:1487-1495
38. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
39. Aebi HE 1983 Catalase. In: Bergmeyer HU, Bergmeyer J, Grassl M, eds. Methods of enzymatic analysis. 3rd ed. Weimheim, Germany: Verlag Chemie; 273-286
40. Hogeboom GH, Schneider WC 1950 Sonic disintegration of isolated liver mitochondria. Nature 166:302-303
41. Vega-Nunez E, Alvarez AM, Menendez-Hurtado A, Santos A, Perez-Castillo A1997 Neuronal mitochondrial morphology and transmembrane potential are severely altered by hypothyroidism during rat brain development. Endocrinology 138:3771-3778
42. Navarro A, Boveris A 2004 Rat brain and liver mitochondria develop oxidative stress and lose enzymatic activities on aging. Am J Physiol Regul Integr Comp Physiol 287:R1244-R1249
43. Pérez R, García-Fernández M, Castilla- Cortázar I, Quiroga J, Delgado G, González-Barón S, Prieto J 2001 Effect of IGF-I on mitochondrial dysfunction in rats with carbon tetrachloride-induced cirrhosis. J Hepatol 34:79
44. Garcia-Segura LM, Sanz A, Mendez P 2006 Cross-talk between IGF-I and estradiol in the brain: focus on neuroprotection. Neuroendocrinology 84:275-279
45. Groban L, Pailes NA, Bennett CD, Carter CS, Chappell MC, Kitzman DW, Sonntag WE 2006 Growth hormone replacement attenuates diastolic dysfunction and cardiac angiotensin II expression in senescent rats. J Gerontol A Biol Sci Med Sci 61:28-35
46. Maggio M, Lauretani F, Ceda GP, Bandinelli S, Basaria S, Paolisso G, Ble A, Egan JM, Metter EJ, Abbatecola AM, Zuliani G, Ruggiero C, Valenti G, Guralnik JM, Ferrucci L 2007 Association of hormonal dysregulation with metabolic syndrome in older women: data from the InCHIANTI study. Am J Physiol Endocrinol Metab 292:353-358
47. Svensson J, Diez M, Engel J, Wass C, Tivesten A, Jansson JO, Isaksson O, Archer T, Hökfelt T, Ohlsson C 2006 Endocrine, liver-derived IGF-I is of importance for spatial learning and memory in old mice. J Endocrinol 189:617-627
48. Sonntag WE, Bennett C, Ingram R, Donahue A, Ingraham J, Chen H, Moore T, Brunso-Bechtold JK, Riddle D 2006 Growth hormone and IGF-I modulate local cerebral glucose utilization and ATP levels in a model of adult-onset growth hormone deficiency. Am J Physiol Endocrinol Metab 291:604-610
49. Aberg ND, Brywe KG, Isgaard J 2006 Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. ScientificWorldJournal 6:53-80
50. Adamo ML, Farrar RP 2006 Resistance training, and IGF involvement in the maintenance of muscle mass during the aging process. Ageing Res Rev 5:310-331
51. Maher FO, Clarke RM, Kelly A, Nally RE, Lynch MA 2006 Interaction between interferon gamma and insulin-like growth factor-1 in hippocampus impacts on the ability of rats to sustain long-term potentiation. J Neurochem 96:1560-1571
52. Messier C, Teutenberg K 2005 The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging and Alzheimer's disease. Neural Plast 12:311-328
53. Zenobi PD, Jaegg-Groisman SE, Riesen WF, Roder ME, Froesch ER 1992 Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus. J Clin Invest 90:2234-2241
54. Castilla-Cortázar I, Aliaga-Montilla MA, Salvador J, García M, Quiroga J, Delgado G, González-Barón, Prieto J 2001 Insulin-like growth factor-I restores the reduced somatostatinergic tone controlling growth hormone secretion in cirrhotic rats. Liver 21:405-409